Impavid is an ITA-based, preclinical-stage medical device and technology platform company focused on highly effective treatments for post-ischemic heart failure. Impavid's patented technology is an innovative cardiac patch classified as class 3 medical device. The device mimics the cardiac extracellular matrix, offering tissue integration and mechanical compliance. It's sterilizable, applicable on a beating heart, and biodegrades without trace, ensuring biocompatibility and tissue preservation. It enables scalable production, lowering costs and time. We have already demonstrated preclinical feasibility and usability in a large animal model. Impavid has upcoming preclinical GLP trials and aims to then carry out a 510(k) FDA submission. Its founders and advisors include some of the most well-known and cited professors and KOLs worldwide in the cardiac tissue engineering space.

Impavid

Roberto Vanni

This department is responsible for strategic direction and overall management of the organization.

Impavid

Org chart

Teams

Executive Leadership

Offices

Impavid

Org chart

Teams

Executive Leadership

Offices

Related companies